• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC. LASSO NAV ECO VARIABLE CATHETER; CATHETER, ELECTRODE RECORDING OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC. LASSO NAV ECO VARIABLE CATHETER; CATHETER, ELECTRODE RECORDING OR PROBE, ELECTRODE RECORDING Back to Search Results
Model Number D134302
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis (2100)
Date of Event 09/30/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The bwi product analysis lab received the complaint device for evaluation.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event or Problem Description
It was reported that a (b)(6) female patient underwent a redo pulmonary vein isolation (pvi) ablation procedure on which a lasso® nav eco variable catheter was used, and thrombosis occurred requiring thrombus aspiration.During the procedure, 10000 units of heparin were administered to the patient.Activated clotting time (act) was 236 seconds.Then, a thrombus was noted post lasso insertion within the left atrium (la) attached to its distal shaft (approximately 1 cm below curved lasso sensor array) between first and second transseptal puncture.Thrombus was confirmed by transesophageal echocardiography (toe).Thrombus was noted prior to the ablation catheter reaching the la.Ablation catheter was at no stage advanced into the left atrium.Nil issues noted upon connecting or flushing the ablation catheter.5000 units of heparin were administered.Act post delivery was 322.3000 u of heparin were then administered.Act post delivery was 359.The thrombus was aspirated with a medium curve agilis sheath.Reminder of the procedure was aborted.The patient did not exhibit neurological symptoms since the procedure was completed.The physician believed the amount of thrombus was excessive, the thrombus was linear independently mobile structure attached to lasso shaft, it was easily recognized on toe despite 10000u of heparin administered prior to the introduction of the lasso.Physician also considered the thrombus to be a significant risk of an embolic event.Catheter was unable to be withdrawn into sheath or back across septum prior to attempts to directly aspirate thrombus due to likelihood of ¿sheering off¿ the thrombus from the catheter.Computerized tomography (ct) of brain was done post catheter removal to exclude stroke.Extended hospitalization was not required.
 
Additional Manufacturer Narrative
It was reported that a 53-year-old female patient underwent a redo pulmonary vein isolation (pvi) ablation procedure on which a lasso® nav eco variable catheter was used, and thrombosis occurred requiring thrombus aspiration.The device was visually inspected, and it was found in good conditions.The magnetic feature was tested, and no issues were observed.In addition, the catheter was deflecting and contracting correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed, and no non-conformances related to the reported complaint were identified.The catheter passed all specifications.The root cause of the adverse event remains unknown.Manufacturer's ref.No: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LASSO NAV ECO VARIABLE CATHETER
Common Device Name
CATHETER, ELECTRODE RECORDING OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BIOSENSE WEBSTER INC.
33 technology drive
irvine CA 92618
MDR Report Key10759350
Report Number2029046-2020-01596
Device Sequence Number3333644
Product Code DRF
UDI-Device Identifier10846835009644
UDI-Public10846835009644
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K113213
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 09/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/20/2023
Device Model NumberD134302
Device Catalogue NumberD134302
Device Lot Number30384438L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/22/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/30/2020
Supplement Date Received by Manufacturer12/09/2020
Initial Report FDA Received Date10/29/2020
Supplement Report FDA Received Date12/22/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MEDIUM CURVE AGILIS SHEATH; UNKNOWN ABLATION CATHETER
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age59 YR
-
-